Shared REMS: US FDA Wants Brisk Brand-Generic Talks, Might Give Unilateral Waivers
New draft guidances are an attempt to curb abuse of REMS single shared system process to delay generic entry.
New draft guidances are an attempt to curb abuse of REMS single shared system process to delay generic entry.